NIH-funded research NIH-funded research

New approaches for long-term pain after repeated mild head injuries

Official title: Novel treatments of chronic pain due to repetitive mild traumatic brain injury

Funded at Rlr VA Medical Center · NIH-11220687 · Data updated 2026-11-12

The project looks at whether blocking a brain inflammation pathway can reduce long-term pain after repeated mild head injuries in people of different ages and sexes.

More Chronic Pain research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRlr VA Medical Center
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startOctober 1, 2023
Project endSeptember 30, 2027
Funding year2025
NIH project number5I01RX004297-03
Project IDNIH-11220687 on NIH RePORTER

Who could benefit from this research

Could help

People with chronic or widespread pain that began after one or more mild concussions or repetitive head impacts — including older adults and Veterans with fall-related head injuries — would be the ideal candidates for future therapies informed by this work.

Less likely to help

Patients whose pain is unrelated to head injury, caused by clear structural damage, or driven mainly by non-inflammatory causes are less likely to benefit from therapies based on this inflammasome pathway.

What this research studies

To understand why some people develop lasting pain after repeated mild head injuries, researchers will use specially engineered mice that light up when a key inflammation enzyme called caspase-1 turns on. They will give controlled mild head impacts to younger and older male and female mice, take live images over time, and map where and when inflammation appears in the brain. By tracking the NLRP3 inflammasome and downstream signals like IL-1β, the team aims to pinpoint how neuroinflammation drives chronic pain and identify targets for new treatments. Findings could guide therapies that block caspase-1 or inflammasome signaling to reduce pain after concussion.

Why it matters

Potential benefit: If successful, this work could point to new inflammation-targeting treatments that reduce or prevent chronic widespread pain after repeated mild head injuries.

How similar studies have gone: Prior animal studies have linked NLRP3/caspase-1 and IL-1β to pain and neuroinflammation with promising preclinical results, but clinical therapies targeting these pathways remain largely unproven.

Where this research is happening

  • Rlr VA Medical Center
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: White, Fletcher a — Rlr VA Medical Center
  • Study coordinator: White, Fletcher a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.